BioCardia, Inc.·4

Sep 5, 12:42 PM ET

McClung David 4

4 · BioCardia, Inc. · Filed Sep 5, 2024

Insider Transaction Report

Form 4
Period: 2024-09-03
McClung David
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2024-09-03$3.00/sh+8,333$24,99917,380 total
  • Award

    Warrant (right to buy)

    2024-09-03+8,3338,333 total
    Exercise: $3.00From: 2024-09-03Exp: 2029-09-03Common Stock (8,333 underlying)
Footnotes (1)
  • [F1]These shares were purchased from the Issuer in a public offering that closed on September 3, 2024, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4